Stocks and Shares
The latest news, updates and opinions on Stocks and Shares from the expert team here at MoneyWeek
Explore Stocks and Shares
-
Unilever braces for inflation amid tariff uncertainty – what does it mean for investors?
Consumer-goods giant Unilever has made steady progress simplifying its operations. Will tariffs now cause turbulence?
By Dr Matthew Partridge Published
-
3 ways to work out if a stock is good value
The only thing you can really control in investing is the price you pay for an asset – but how can you tell if you’re getting a good deal when it comes to the price of a stock?
By Laura Miller Published
-
Magnificent Seven earnings: Amazon and Apple beat expectations but shares drop
Amazon and Apple beat expectations when they published their earnings reports on 1 May, but shares dropped in after-hours trading as investors honed in on other key metrics
By Dan McEvoy Last updated
-
'Technology will determine tomorrow’s top stocks in emerging markets'
Opinion John Citron, investment manager of the JPMorgan Emerging Markets Investment Trust, tells us where he’d put his money
By John Citron Published
Opinion -
Which investments can I hold in a stocks and shares ISA – and which ones are banned?
HMRC has a list stating which investments are allowed in ISAs, but sometimes investors, and even ISA providers, get confused by the rules. Here’s what you need to know when picking your investments.
By Ruth Emery Last updated
-
M&S share price plunges 7% after cyberattack – what does it mean for investors?
Around £700 million has been wiped off Marks & Spencer’s market value over the past week, as the fallout from its cyberattack continues
By Katie Williams Published
-
Three British mid-caps that could make 'attractive' investments
Opinion Charles Luke, manager of the Murray Income Trust, highlights three UK-listed mid-cap companies, as he tells us where he'd put his money
By Charles Luke Published
Opinion -
Should you invest in UK dividend stocks?
UK dividends totalled £14 billion in the first quarter, falling 4.6% annually but still beating expectations. Which sectors were the top payers, and will Trump’s tariffs prompt cuts?
By Katie Williams Published
-
Precision-engineered profits: How to invest in genomics
Developments in genomics are enabling the rise of personalised medicine, with therapies tailored specifically for individuals. Smart investors should buy in now, says Matthew Partridge
By Dr Matthew Partridge Published